FDA Issues Untitled Letter To Bausch Health Companies For Misleading Statements Relating To DUOBRII[TM]

Authors :: Costopoulos, Eve
Source :: Mondaq Business Briefing. April 20, 2022
Publication Year :: 2022
Abstract: On March 31, 2022, the Office of Prescription Drug Promotion (OPDP) of the U.S. Food and Drug Administration (FDA) issued an untitled letter to Bausch Health Companies Inc. regarding a [...]

Subjects :: United States. Food and Drug Administration -- Powers and duties
Bausch Health Companies Inc. -- Advertising
Advertising -- Laws, regulations and rules
False advertising -- Laws, regulations and rules
Advertising law -- Interpretation and construction
Pharmaceutical industry -- Advertising
Government regulation
Business, international

Tools